drug development
Danaher Launches US, UK Laboratories for Precision Medicine Test Development
The CLIA- and CAP-certified laboratories are intended to accelerate the development of companion diagnostics and complementary diagnostics.
Nucleai Raises $14M in Funding Round Led by Merck KGaA's M Ventures
The company said it will use the funds to further apply its AI algorithms in the prospective enrollment of patients in clinical trials.
Investigational Cancer Drug Deemed Highly Mutagenic in Cell Line Sequencing Study
Using whole-genome sequencing on drug-exposed cell lines, researchers saw high mutation rates in control cell lines intermittently treated with a compound called CX-5461.
Adaptive Biotechnologies, BeiGene Partner for Lymphoid Malignancy Drug Development
Adaptive’s ClonoSeq assay will be used to assess MRD across BeiGene’s pipeline of treatments for patients with lymphoid malignancies.
Study Compares Abilities of Various Genetic Approaches to Identify Drug Targets
This study finds that GWAS and exome sequencing outrank other approaches in identifying drug targets.